StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Elutia profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Elutia's profit margin for the twelve months ending Jun 30, 2026 was 426.9%. For fiscal 2025 it was 434.2%, against -372.9% the year before. The highest annual figure on record is 434.2% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025434.2%+807.1
FY2024Dec 31, 2024-372.9%−220.7
FY2023Dec 31, 2023-152.2%−14.2
FY2022Dec 31, 2022-137.9%−85.5
FY2021Dec 31, 2021-52.4%−1.3
FY2020Dec 31, 2020-51.1%−23.3
FY2019Dec 31, 2019-27.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-315.0%+34.8
Q1 FY2026Mar 31, 2026-239.9%−106.6
Q4 FY2025Dec 31, 20252164.2%+2486.0
Q3 FY2025Sep 30, 2025-116.4%−151.5
Q2 FY2025Jun 30, 2025-349.8%+98.1
Q1 FY2025Mar 31, 2025-133.3%+135.5
Q4 FY2024Dec 31, 2024-321.8%−163.2
Q3 FY2024Sep 30, 202435.1%+194.2
Q2 FY2024Jun 30, 2024-447.9%−280.7
Q1 FY2024Mar 31, 2024-268.8%−144.1
Q4 FY2023Dec 31, 2023-158.5%−84.2
Q3 FY2023Sep 30, 2023-159.1%−88.2
Q2 FY2023Jun 30, 2023-167.2%−83.8
Q1 FY2023Mar 31, 2023-124.7%−52.3
Q2 FY2022Jun 30, 2022-74.4%−54.7
Q1 FY2022Mar 31, 2022-70.9%−31.6
Q4 FY2021Dec 31, 2021-83.5%−40.5
Q3 FY2021Sep 30, 2021-72.4%−15.2
Q2 FY2021Jun 30, 2021-19.6%+40.7
Q1 FY2021Mar 31, 2021-39.3%+6.9
Q4 FY2020Dec 31, 2020-43.0%−19.9
Q3 FY2020Sep 30, 2020-57.2%−29.3
Q2 FY2020Jun 30, 2020-60.4%–
Q1 FY2020Mar 31, 2020-46.2%–
Q4 FY2019Dec 31, 2019-23.1%–
Q3 FY2019Sep 30, 2019-27.9%–

More Elutia figures

See a number that looks wrong?